{"id":507361,"date":"2021-06-28T17:30:56","date_gmt":"2021-06-28T21:30:56","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\/"},"modified":"2021-06-28T17:30:56","modified_gmt":"2021-06-28T21:30:56","slug":"athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\/","title":{"rendered":"ATHIRA PHARMA INVESTOR ALERT: Have You Suffered Losses Greater Than $100,000 Investing In Athira Pharma? Kehoe Law Firm, P.C. Securities Class Action Investigation"},"content":{"rendered":"
\n

PHILADELPHIA, June 28, 2021 (GLOBE NEWSWIRE) — Kehoe Law Firm, P.C. is investigating potential securities claims<\/a> on behalf of investors of Athira Pharma, Inc. (\u201cAthira\u201d <\/strong>or the \u201cCompany\u201d) (<\/strong>NASDAQ: ATHA<\/strong><\/a>) <\/strong>to determine whether the Company engaged in securities fraud or other unlawful business practices.<\/p>\n

\n Class action lawsuits have been filed in United States District Court on behalf of purchasers of the securities of Athira (a) pursuant and\/or traceable to the Company\u2019s initial public offering (\u201cIPO\u201d) conducted in September 2020; and\/or (b) between September 18, 2020 and June 17, 2021, both dates inclusive (the \u201cClass Period\u201d). <\/strong>\n <\/p>\n

According to the lawsuits, the IPO documents contained and defendants made false and\/or misleading statements and\/or failed to disclose that (1) the research conducted by the Company\u2019s Chief Executive Officer and President, Leen Kawas (\u201cKawas\u201d), was tainted by Kawas\u2019 scientific misconduct, including the manipulation of key data through the altering of Western blot images; (2) this purported research was foundational to Athira\u2019s efforts to develop treatments for Alzheimer\u2019s because it laid the biological groundwork that Athira was using in its approach to treating Alzheimer\u2019s; (3) as a result, Athira\u2019s intellectual property and product development for the treatment of Alzheimer\u2019s was based on invalid research; and (4) as a result of the foregoing, the Athira defendants\u2019 positive statements about the Company\u2019s business, operations, and prospects, were materially misleading and\/or lacked a reasonable basis.<\/p>\n

\n INVESTORS WHO PURCHASED, OR OTHERWISE ACQUIRED, ATHIRA SECURITIES PURSUANT AND\/OR TRACEABLE TO ATHIRA\u2019S IPO AND\/OR DURING THE CLASS PERIOD AND SUFFERED LOSSES GREATER THAN $100,000 ARE ENCOURAGED TO COMPLETE KEHOE LAW FIRM\u2019S <\/strong>
\n
\n SECURITIES CLASS ACTION QUESTIONNAIRE<\/strong>
\n <\/a>
\n OR CONTACT MICHAEL YARNOFF, ESQ., MYARNOFF@KEHOELAWFIRM.COM, <\/strong>
\n
\n SECURITIES@KEHOELAWFIRM.COM<\/strong>
\n <\/a>
\n , <\/strong>
\n
\n INFO@KEHOELAWFIRM.COM<\/strong>
\n <\/a>
\n , TO DISCUSS THE\u00a0<\/strong>
\n SECURITIES CLASS ACTION INVESTIGATION OR POTENTIAL LEGAL CLAIMS. <\/strong>\n <\/p>\n

\n Kehoe Law Firm, P.C.<\/a>, with offices in New York and Philadelphia, is a multidisciplinary, plaintiff\u2013side law firm dedicated to protecting investors from securities fraud, breaches of fiduciary duties, and corporate misconduct.\u00a0 Combined, the partners at Kehoe Law Firm have served as Lead Counsel or Co-Lead Counsel in cases that have recovered more than $10 billion on behalf of institutional and individual investors.\u00a0\u00a0\u00a0<\/p>\n

This press release may constitute attorney advertising.<\/p>\n

\n
\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

PHILADELPHIA, June 28, 2021 (GLOBE NEWSWIRE) — Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Athira Pharma, Inc. (\u201cAthira\u201d or the \u201cCompany\u201d) (NASDAQ: ATHA) to determine whether the Company engaged in securities fraud or other unlawful business practices. Class action lawsuits have been filed in United States District Court on behalf of purchasers of the securities of Athira (a) pursuant and\/or traceable to the Company\u2019s initial public offering (\u201cIPO\u201d) conducted in September 2020; and\/or (b) between September 18, 2020 and June 17, 2021, both dates inclusive (the \u201cClass Period\u201d). According to the lawsuits, the IPO documents contained and defendants made false and\/or misleading statements and\/or failed to disclose that (1) the research conducted by … <\/p>\n

Continue reading “ATHIRA PHARMA INVESTOR ALERT: Have You Suffered Losses Greater Than $100,000 Investing In Athira Pharma? Kehoe Law Firm, P.C. Securities Class Action Investigation”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-507361","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nATHIRA PHARMA INVESTOR ALERT: Have You Suffered Losses Greater Than $100,000 Investing In Athira Pharma? Kehoe Law Firm, P.C. Securities Class Action Investigation - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ATHIRA PHARMA INVESTOR ALERT: Have You Suffered Losses Greater Than $100,000 Investing In Athira Pharma? Kehoe Law Firm, P.C. Securities Class Action Investigation - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA, June 28, 2021 (GLOBE NEWSWIRE) — Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Athira Pharma, Inc. (\u201cAthira\u201d or the \u201cCompany\u201d) (NASDAQ: ATHA) to determine whether the Company engaged in securities fraud or other unlawful business practices. Class action lawsuits have been filed in United States District Court on behalf of purchasers of the securities of Athira (a) pursuant and\/or traceable to the Company\u2019s initial public offering (\u201cIPO\u201d) conducted in September 2020; and\/or (b) between September 18, 2020 and June 17, 2021, both dates inclusive (the \u201cClass Period\u201d). According to the lawsuits, the IPO documents contained and defendants made false and\/or misleading statements and\/or failed to disclose that (1) the research conducted by … Continue reading "ATHIRA PHARMA INVESTOR ALERT: Have You Suffered Losses Greater Than $100,000 Investing In Athira Pharma? Kehoe Law Firm, P.C. Securities Class Action Investigation"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-28T21:30:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MTc5MyM0MjczMDY4IzIxMjEyMjQ=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ATHIRA PHARMA INVESTOR ALERT: Have You Suffered Losses Greater Than $100,000 Investing In Athira Pharma? Kehoe Law Firm, P.C. Securities Class Action Investigation\",\"datePublished\":\"2021-06-28T21:30:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\\\/\"},\"wordCount\":387,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MTc5MyM0MjczMDY4IzIxMjEyMjQ=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\\\/\",\"name\":\"ATHIRA PHARMA INVESTOR ALERT: Have You Suffered Losses Greater Than $100,000 Investing In Athira Pharma? Kehoe Law Firm, P.C. Securities Class Action Investigation - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MTc5MyM0MjczMDY4IzIxMjEyMjQ=\",\"datePublished\":\"2021-06-28T21:30:56+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MTc5MyM0MjczMDY4IzIxMjEyMjQ=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODI3MTc5MyM0MjczMDY4IzIxMjEyMjQ=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ATHIRA PHARMA INVESTOR ALERT: Have You Suffered Losses Greater Than $100,000 Investing In Athira Pharma? Kehoe Law Firm, P.C. Securities Class Action Investigation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ATHIRA PHARMA INVESTOR ALERT: Have You Suffered Losses Greater Than $100,000 Investing In Athira Pharma? Kehoe Law Firm, P.C. Securities Class Action Investigation - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\/","og_locale":"en_US","og_type":"article","og_title":"ATHIRA PHARMA INVESTOR ALERT: Have You Suffered Losses Greater Than $100,000 Investing In Athira Pharma? Kehoe Law Firm, P.C. Securities Class Action Investigation - Market Newsdesk","og_description":"PHILADELPHIA, June 28, 2021 (GLOBE NEWSWIRE) — Kehoe Law Firm, P.C. is investigating potential securities claims on behalf of investors of Athira Pharma, Inc. (\u201cAthira\u201d or the \u201cCompany\u201d) (NASDAQ: ATHA) to determine whether the Company engaged in securities fraud or other unlawful business practices. Class action lawsuits have been filed in United States District Court on behalf of purchasers of the securities of Athira (a) pursuant and\/or traceable to the Company\u2019s initial public offering (\u201cIPO\u201d) conducted in September 2020; and\/or (b) between September 18, 2020 and June 17, 2021, both dates inclusive (the \u201cClass Period\u201d). According to the lawsuits, the IPO documents contained and defendants made false and\/or misleading statements and\/or failed to disclose that (1) the research conducted by … Continue reading \"ATHIRA PHARMA INVESTOR ALERT: Have You Suffered Losses Greater Than $100,000 Investing In Athira Pharma? Kehoe Law Firm, P.C. Securities Class Action Investigation\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\/","og_site_name":"Market Newsdesk","article_published_time":"2021-06-28T21:30:56+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MTc5MyM0MjczMDY4IzIxMjEyMjQ=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ATHIRA PHARMA INVESTOR ALERT: Have You Suffered Losses Greater Than $100,000 Investing In Athira Pharma? Kehoe Law Firm, P.C. Securities Class Action Investigation","datePublished":"2021-06-28T21:30:56+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\/"},"wordCount":387,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MTc5MyM0MjczMDY4IzIxMjEyMjQ=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\/","name":"ATHIRA PHARMA INVESTOR ALERT: Have You Suffered Losses Greater Than $100,000 Investing In Athira Pharma? Kehoe Law Firm, P.C. Securities Class Action Investigation - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MTc5MyM0MjczMDY4IzIxMjEyMjQ=","datePublished":"2021-06-28T21:30:56+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MTc5MyM0MjczMDY4IzIxMjEyMjQ=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODI3MTc5MyM0MjczMDY4IzIxMjEyMjQ="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/athira-pharma-investor-alert-have-you-suffered-losses-greater-than-100000-investing-in-athira-pharma-kehoe-law-firm-p-c-securities-class-action-investigation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ATHIRA PHARMA INVESTOR ALERT: Have You Suffered Losses Greater Than $100,000 Investing In Athira Pharma? Kehoe Law Firm, P.C. Securities Class Action Investigation"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/507361","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=507361"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/507361\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=507361"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=507361"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=507361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}